The Mumbai-based has already receive a letter of interest from the European pharma firm to acquire
The move is a result of the company's strategy to consolidate its manufacturing activity in the US
The seminar the benefit of extractables and leachables testing for understanding the influence of material used in pharmaceutical process
The UK-based company will continue to hold directly its interests in the listed Indian entity
Swiss firm will leverage HCL's global delivery model for remote infrastructure management services across its entire data centre landscape, covering more than 70 countries
The company has entered into technical collaboration with the University of Chemnitz, Germany
Bangalore based firm will build and maintain an 'as-a-service' global platform for Takeda that will drive synergies across its global entities through standardisation of IT architecture
The commercial production at Sharon's two expanded plants at Taloja near Navi Mumbai have already started, while Dehradun formulation expanded facility will start production from June 2014
With projects worth Rs 4.08 lakh crore cleared by Cabinet Committee on Investment, chemical process equipment manufacturers in India expect better prospects in 2014
With the facility Glenmark has end-to-end capabilities for the development of novel, state-of-the-art monoclonal antibodies including bi-specific antibodies
Despite investment incentives, limited access to healthcare facilities and governmental cuts could impede further growth in the future, according to GlobalData
Cipla New Ventures to invest in the US-based firm as part of a syndicate, which also consists of Edmond de Rothschild Investment Partners and New Rhein Healthcare
Satish Reddy appointed as Chairman of the Board, while G V Prasad has been appointed as the Co-Chairman, CEO and MD. The company also appoints Abhijit Mukherjee as COO
Dr Nageswara Rao, 87, earlier served as a Director of Hindustan Antibiotics
The approval provides Vivimed with a significant opportunity to penetrate the CIS markets
The move will enhance Abbott's position in fast-growing Latin American market, more than double its branded generics pharmaceutical sales and presence in the region
The European pharma firm proposed last month to buy Dr Datsons Labs
The new production facility in Bari, Italy, which is expected to be commissioned in 2017, will meet the rising demand for biopharmaceuticals
The technology to produce biodegradable edible films for food and pharmaceutical packaging from natural resources have been developed by BARC
The company, which is planning for a global product launch in July 2014, intends to establish a small scale experimental lab to enable in-house R&D